The state continues to provide incentives for health care providers to begin treating opioid use disorders.
The Delaware Division of Addiction and Mental Health (DSAMH) is offering up to $ 100,000 to providers who wish to begin screening for opioid use disorders and refer patients for treatment. And it will pay up to $ 500,000 to those who start treating patients with opioid use disorders using drugs like buprenorphine.
“This grant opportunity mechanism is really about recruiting new people into the space while increasing current capacity,” said Brent Waninger, DSAMH’s head of workforce development and education. “So really trying to get those who are maybe a little bit shy about going into space.”
These grants are funded with federal dollars. State dollars have also been earmarked for this matter under a similar program announced two months ago in the Delaware division of Medicaid and Medical Assistance.
Waninger says that, like the Medicaid program, fellows will be enrolled in the state’s network of opioid response providers.
“Learn in this collaborative best practice learning space, what works in the environment for clients in different geographies of the state, different practice settings in the state,” he said. .
Grant applications are due June 14, and funded projects can begin as early as the beginning of July.
Delaware had the second highest overdose death rate in the country in 2019 with 431 deaths, and officials say that number rose to 446 last year.